Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure (Q40082899)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2013
edit
Language Label Description Also known as
English
Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure
scientific article published on January 2013

    Statements

    Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure (English)
    Urban Alehagen
    Ulf Dahlström
    Jens F Rehfeld
    Jens P Goetze
    1 January 2013
    31-39

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit